HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing in Brief: Nizoral AD switch

This article was originally published in The Rose Sheet

Executive Summary

Nizoral AD switch: Ads for J&J Consumer's Rx-to-OTC switch dandruff shampoo (1% ketoconazole) are being created by McCann Ericson, based in Manhattan. Spots to professionals announcing the switch will be handled by Quantum Consumer, a division of CommonHealth, based in Parsippany, N.J.; Thomas Ferguson, which handles advertising for the prescription brand, also is a division of CommonHealth. Ad budget and a launch date have not been disclosed. Nizoral AD was approved for the OTC treatment of dandruff on Oct. 10 ("The Rose Sheet" Oct. 20, p. 1)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel